YK012
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for YK012, covering 2025-11-17 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus [Phase 1]